UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040525
Receipt number R000046219
Scientific Title Long-term immunogenicity after rabies vaccination among Japanese people
Date of disclosure of the study information 2020/06/01
Last modified on 2023/11/29 02:16:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term immunogenicity after rabies vaccination among Japanese people

Acronym

Long-term immunogenicity after rabies vaccination among Japanese people

Scientific Title

Long-term immunogenicity after rabies vaccination among Japanese people

Scientific Title:Acronym

Long-term immunogenicity after rabies vaccination among Japanese people

Region

Japan


Condition

Condition

Rabies

Classification by specialty

Medicine in general Infectious disease Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to evaluate the immunogenicity after more than 2 years of rabies vaccination.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Seropositive rate of antibody titers for rabies virus

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Japanese adults who received with rabies vaccine more than 2 years ago

Key exclusion criteria

no restriction

Target sample size

100


Research contact person

Name of lead principal investigator

1st name SHINJI
Middle name
Last name FUKUSHIMA

Organization

Tokyo Medical University Hospital

Division name

Travellers' Medical Center

Zip code

160-0023

Address

6-7-1 Nishishinjuku, Shinjuku, Tokyo, Japan

TEL

+81-3-5339-3726

Email

fuku789@tokyo-med.ac.jp


Public contact

Name of contact person

1st name SHINJI
Middle name
Last name FUKUSHIMA

Organization

Tokyo Medical University Hospital

Division name

Travellers' Medical Center

Zip code

160-0023

Address

6-7-1 Nishishinjuku, Shinjuku, Tokyo, Japan

TEL

+81-3-5339-3726

Homepage URL


Email

fuku789@tokyo-med.ac.jp


Sponsor or person

Institute

Tokyo Medical University Hospital
Travellers' Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical University Hospital
Travellers' Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical University, Institutional Review Board

Address

6-7-1 Nishishinjuku, Shinjuku, Tokyo, Japan

Tel

03-3342-6111

Email

IRB@tokyo-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2020 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 02 Month 28 Day

Date of IRB

2017 Year 02 Month 28 Day

Anticipated trial start date

2020 Year 07 Month 27 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Descriptive study


Management information

Registered date

2020 Year 05 Month 26 Day

Last modified on

2023 Year 11 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046219


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name